Related Experiment Videos
Techniques used to define human MHC antigens: restriction fragment length polymorphisms
1Northern Ireland Tissue Typing Laboratory, Belfast City Hospital, U.K.
Immunology Letters
|July 1, 1991
Summary
Restriction fragment length polymorphism (RFLP) analysis detects human leukocyte antigen (HLA) gene variations. This method complements serology, offering valuable quality control for HLA typing and resolving ambiguities in B cell analysis.
Area of Science:
- Immunogenetics
- Molecular Biology
- Human Genetics
Background:
- Human leukocyte antigen (HLA) gene polymorphisms are crucial for immune response.
- Serological methods for HLA typing can be limited by B cell quality and antiserum availability.
- Defining specific HLA subtypes is essential for transplantation and disease association studies.
Purpose of the Study:
- To describe a Restriction Fragment Length Polymorphism (RFLP) method for analyzing HLA-DRB1, -DRB3, -DQB1, and -DQA1 gene polymorphisms.
- To evaluate the utility of RFLP as a complementary technique to serological HLA typing.
- To assess RFLP's role in quality control for HLA typing methods.
Main Methods:
- DNA isolation from blood, spleen, or lymph nodes.
- Digestion with TaqI restriction endonuclease and agarose gel electrophoresis.
- Southern blotting, hybridization with radiolabeled cDNA probes (HLA-DR beta, HLA-DQ beta, HLA-DQ alpha), and autoradiography.
Main Results:
- RFLP successfully detects polymorphisms in HLA-DR and -DQ genes.
- The technique is valuable when serological typing is difficult or ambiguous.
- RFLP can define HLA subtypes and resolve discrepancies between typing centers.
- Linkage disequilibrium aids in determining DR alleles from DQ alleles.
Conclusions:
- RFLP analysis is a valuable adjunct to serological HLA typing, particularly for difficult cases and quality control.
- It complements serological methods by providing high-resolution typing and resolving ambiguities.
- While time-restricted for prospective cadaver donor typing, RFLP enhances the reliability of HLA characterization.